Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Tamoxifen price, strengths & recalls

Generic of Soltamox

Pharmacies pay $8.24 for 30 tablets of Tamoxifen 20 mg tablet this week, and from $3.96 to $8.24 across its 2 priced strengths and forms. 10 manufacturers make it. It has 1 recall on record, none ongoing. Its official label last changed on December 19, 2025.

Generic
Pharmacies pay$8.24for 30 tablets of 20 mg tablet-0.8% in 4 weeks
Fair cash price
$19.98
Strengths
2
Makers
10
Updated
Nov 11

Tamoxifen price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
10 mg tablet$0.1321$3.96 / 30 tablets+5.2%-13.2%
20 mg tablet$0.2747$8.24 / 30 tablets-0.8%-4.8%

Brand names of tamoxifen

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls1 recall on record, latest Apr 29, 2015

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for tamoxifen? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedDecember 19, 2025
Version8 of 7
EffectiveDec 18, 2025
Read the label

Tamoxifen Citrate Tablets, USPRx only

This drug has a boxed warning

WARNING

For Women with Ductal Carcinoma in Situ (DCIS) and Women at High Risk for Breast Cancer

Serious and life-threatening events associated with tamoxifen in the risk reduction setting (women at high risk for cancer and women with DCIS) include uterine malignancies, stroke and pulmonary embolism. Incidence rates for these events were estimated from the NSABP P-1 trial (see CLINICAL PHARMACOLOGY, Clinical Studies, Reduction in Breast Cancer Incidence in High Risk Women). Uterine malignancies consist of both endometrial adenocarcinoma (incidence rate per 1,000 women-years of 2.20 for tamoxifen vs. 0.71 for placebo) and uterine sarcoma (incidence rate per 1,000 women-years of 0.17 for tamoxifen vs. 0.4 for placebo)*. For stroke, the incidence rate per 1,000 women-years was 1.43 for tamoxifen vs. 1.00 for placebo**. For pulmonary embolism, the incidence rate per 1,000 women-years was 0.75 for tamoxifen versus 0.25 for placebo**.

Some of the strokes, pulmonary emboli, and uterine malignancies were fatal.

Health care providers should discuss the potential benefits versus the potential risks of these serious events with women at high risk of breast cancer and women with DCIS considering tamoxifen to reduce their risk of developing breast cancer.

The benefits of tamoxifen citrate outweigh its risks in women already diagnosed with breast cancer.

*Updated long-term follow-up data (median length of follow-up is 6.9 years) from NSABP P-1 study. See WARNINGS: Effects on the Uterus-Endometrial Cancer and Uterine Sarcoma.

**See Table 3 under CLINICAL PHARMACOLOGY, Clinical Studies.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021807 · Mayne Pharma Commrcl
First approved
October 29, 2005 (21 years ago)
Latest approved change
April 8, 2019
Approved label
PDF, Apr 9, 2019
Generic makers
4 approved generic applications on the market

Tamoxifen questions

How much does tamoxifen cost without insurance?

Pharmacies pay about $8.24 for 30 tablets of tamoxifen 20 mg tablet ($0.2747 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $19.98. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of tamoxifen?

Tamoxifen is sold as Soltamox. The generic has the same active ingredient and usually costs far less.

Is tamoxifen in shortage?

No shortage is reported for tamoxifen right now. We check the national shortage list every day.

Has tamoxifen been recalled?

1 recall on record, none ongoing. Recalls name specific lots - check yours.

When did the tamoxifen label last change?

The official label was last updated on December 19, 2025 (version 8). See what changed.

Talk about tamoxifen

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.